Home > Financial Ratios > LYKA LABS

LYKA LABS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.261.421.800.982.27

What is the latest Fixed Capital/Sales ratio of LYKA LABS ?

The latest Fixed Capital/Sales ratio of LYKA LABS is 1.26 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.26
Mar20241.42
Mar20231.80
Mar20220.98
Mar20212.27

How is Fixed Capital/Sales of LYKA LABS Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.26
-11.27
Mar2024 1.42
-21.11
Mar2023 1.8
83.67
Mar2022 0.98
-56.83
Mar2021 2.27 -

Other Financial Ratios of LYKA LABS


Compare Fixed Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹281.8 Cr -3.5% 4.6% -49.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,631.0 Cr 1.9% -0.8% -3.5% Stock Analytics
DIVIS LABORATORIES ₹175,111.0 Cr 3.2% 4.8% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,228.0 Cr 6.3% 8.9% 15.8% Stock Analytics
CIPLA ₹117,983.0 Cr -3.3% -2% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,782.0 Cr -3.8% -3.1% -8% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-3.5%

4.6%

-49.5%

SENSEX

-1.2%

-1.1%

6.3%


You may also like the below Video Courses